HEMOGLOBIN A1C TESTING DEVICES MARKET ANALYSIS

Hemoglobin A1c Testing Devices MarketSize and Trends

Statistics:

The global hemoglobin A1c testing devices market is estimated to account for US$ 4,129.4 Mn in terms of value by the end of 2027.

Statistics:

North America held dominant position in the global hemoglobin A1c testing devices market in 2019, accounting for 36.8% share in terms of value, followed by Europe and Asia Pacific, respectively

Statistics:

The global hemoglobin A1c testing devices market was valued at US$ 1,863.7 Mn in 2019 and is forecast to reach a value of US$ 4,129.4 Mn by 2027 at a CAGR of 10.5% between 2020 and 2027.

Figure 2: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn), 2016 - 2027

Market Trends/Key Takeaways

The current trend is shifting towards the Clinical Laboratory Improvement Amendments (CLIA) waived tests and hence manufacturing CLIA waived tests will bolster the demand for CLIA waived HbA1c testing devices. Moreover, introduction of CLIA waived POC HbA1c testing devices will increase the market demand for POC devices and thus in turn will be beneficial for both manufacturers as well as customers.

Several studies have demonstrated higher efficacy of glucose tolerance test over hemoglobin A1c blood test. For instance, in March 2019, a study by City of Hope Diabetes and Metabolism Research Institute, published at the Endocrine Society’s ENDO 2019, reported that hemoglobin A1c blood test missed almost 73% of the people with diabetes in comparison to the oral glucose tolerance test.